Comparative results of treatment for chronic hepatitis C in HIV-infected patients receiving and not receiving highly active antiretroviral therapy



如何引用文章

全文:

详细

The paper presents the comparative results of treatment for chronic hepatitis C in HIV-infected patients in two groups: those who receive and do not receive highly active antiretroviral therapy (HAART). The findings indicated that the efficiency of therapy for hepatitis was comparable in both groups: the proportions of patients with a steady-state virological response who received and did not receive HAART were 34.1 and 40.9%, respectively. Some adverse reactions significantly differed in their frequency in both groups. Nevertheless, their severity was that which did not require hepatitis therapy discontinuance.

作者简介

S Minayeva

Nizhni Novgorod Regional Center for Prevention and Control of AIDS and Infectious Diseases, Nizhni Novgorod

Email: mistella@yandex.ru
Nizhni Novgorod Regional Center for Prevention and Control of AIDS and Infectious Diseases, Nizhni Novgorod

G Moshkovich

Nizhni Novgorod Regional Center for Prevention and Control of AIDS and Infectious Diseases, Nizhni Novgorod

Nizhni Novgorod Regional Center for Prevention and Control of AIDS and Infectious Diseases, Nizhni Novgorod

M Goryaeva

Nizhni Novgorod Regional Center for Prevention and Control of AIDS and Infectious Diseases, Nizhni Novgorod

Nizhni Novgorod Regional Center for Prevention and Control of AIDS and Infectious Diseases, Nizhni Novgorod

L Varlova

Nizhni Novgorod Regional Center for Prevention and Control of AIDS and Infectious Diseases, Nizhni Novgorod

Nizhni Novgorod Regional Center for Prevention and Control of AIDS and Infectious Diseases, Nizhni Novgorod

I Voronina

Nizhni Novgorod Regional Center for Prevention and Control of AIDS and Infectious Diseases, Nizhni Novgorod

Nizhni Novgorod Regional Center for Prevention and Control of AIDS and Infectious Diseases, Nizhni Novgorod

参考

  1. Методические рекомендации Федерального научно-методического центра по профилактике и борьбе со СПИДом Роспотребнадзора "Диспансерное наблюдение, лечение и профилактика вирусных гепатитов у подростков и взрослых, больных ВИЧ-инфекцией" / Кравченко А. В., Ганкина Н. Ю., Канестри В. Г. и др. - М., 2007.
  2. Кравченко А. В., Ганкина Н. Ю., Канестри В. Г. Особенности антиретровирусной терапии при сочетании ВИЧ-инфекции и хронического вирусного гепатита // Фарматека. - 2008. № 19. - С. 1-8.
  3. Шахгильдян В. И. Современные подходы к лечению HCV-инфекции у ВИЧ-инфицированных // Гепатол. форум. - 2008. - № 4. - С. 16-27.
  4. Bannister W. P., Mocroft A. et al. Opportunistic infections in immunocompromised but virologically suppressed HIV-1 infected patients // 9-th International Congress on Drug Therapy in HIV Infection, Glazgow, UK, 9-13 Nov., 2008. - Glazgow, 2008. - P. 13.
  5. Crum N. F., Riffenburgh R. H., Wegner S. et al. Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early and late HAART eras // J. Acquir. Immune Defic. Syndr. - 2006. - Vol. 41. - P. 194-200.
  6. Laguno M., Murillas J., Blanco J. L. et al. Peginterferon Alfa-2b plus ribavirin compared with interferon Alfa-2b plus ribavirin for treatment HIV/HCV coinfected patients // AIDS. - 2004. - Vol. 18. - P. F27-F36.
  7. Mallolas J., Laguno M. Peginterferon Alfa-2b plus ribavirin for treatment naive patients coinfected with HCV and HIV // Expert. Rev. Antiinfect. Ther. - 2008. - Vol. 6. - P. 281-289.
  8. Moshkovich G., Minaeva S., Tichonova E., Sandova 0. HCV Genotypes distribution in the Nizhny Novgorod area HIV-positive population // 9-th International Congress on Drug Therapy in HIV Infection, Glazgow, UK, 9-13 Nov., 2008. - Glazgow, 2008. - P. 110.
  9. Soriano V., Barriero P., Nunez M. Management of chronic hepatitis B and C in HIV-coinfected patients // J. Antimicrob. Chemother. - 2006. - Vol. 57. - P. 815-818.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Eco-vector, 2010



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 80652 от 15.03.2021
. Учредитель ООО "Эко-Вектор Ай-Пи" (ОГРН 1157847215338).